Vice President, CMC Biologics

Dr. Tsvetnitsky is an experienced biotechnology professional with more than 21 years of experience developing antibodies and vaccines. Vadim’s particular experience is in leading complex CMC development projects. After obtaining undergraduate degree in chemical engineering he earned Ph.D. in biochemistry from the University of London School of Pharmacy. Vadim subsequently completed post-doctoral training in protein biochemistry and molecular biology prior to directing multiple product development teams while holding positions of increased responsibility at Cangene, PATH, IAVI and Codagenix. Vadim has deep expertise in all aspects of CMC, pre-clinical development, regulatory writing, early stage clinical trials and technical operations.